Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Experience Starting an Addiction Medicine Practice-based Research Network.
Ibrahim A, Clarke DE, Gibson D, Casanova B, Pagano A, Vocci FJ, Goldstein A, Patel S, Rahman N, Schwartz RP. Ibrahim A, et al. Among authors: vocci fj. J Addict Med. 2024 Nov-Dec 01;18(6):689-695. doi: 10.1097/ADM.0000000000001354. Epub 2024 Jul 30. J Addict Med. 2024. PMID: 39078061
Revisiting Preaddiction.
Miller SC, Levy S, Saxon AJ, Tetrault JM, Rosenthal RN, Wakeman S, Vocci F. Miller SC, et al. J Addict Med. 2024 Sep-Oct 01;18(5):486-487. doi: 10.1097/ADM.0000000000001357. Epub 2024 Aug 10. J Addict Med. 2024. PMID: 39356619
Efficacy and Safety of Esmethadone (REL-1017) in Patients With Major Depressive Disorder and Inadequate Response to Standard Antidepressants: A Phase 3 Randomized Controlled Trial.
Fava M, Stahl SM, Pani L, De Martin S, Cutler AJ, Maletic V, Gorodetzky CW, Vocci FJ, Sapienza FL, Kosten TR, Kröger C, Champasa P, O'Gorman C, Guidetti C, Alimonti A, Comai S, Mattarei A, Folli F, Bushnell D, Traversa S, Inturrisi CE, Manfredi PL, Pappagallo M. Fava M, et al. Among authors: vocci fj. J Clin Psychiatry. 2024 Jun 17;85(3):24m15265. doi: 10.4088/JCP.24m15265. J Clin Psychiatry. 2024. PMID: 38917366 Clinical Trial.
Letter to the Editor regarding 'Unique pharmacodynamic properties and low abuse liability of the µ-opioid receptor ligand (S)-methadone'.
Pappagallo M, Kosten TR, Gorodetzky CW, Vocci FJ, Sapienza FL, De Martin S, Comai S, Mattarei A, Inturrisi CE, Manfredi PL. Pappagallo M, et al. Among authors: vocci fj. Mol Psychiatry. 2024 Dec;29(12):3935-3937. doi: 10.1038/s41380-024-02621-6. Epub 2024 May 28. Mol Psychiatry. 2024. PMID: 38806691 Free PMC article. No abstract available.
Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.
Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. Henningfield JE, et al. Among authors: vocci fj. Neuropharmacology. 2022 Nov 1;218:109220. doi: 10.1016/j.neuropharm.2022.109220. Epub 2022 Aug 17. Neuropharmacology. 2022. PMID: 35987353 Free article. Review.
A clinical protocol of a comparative effectiveness trial of extended-release naltrexone versus extended-release buprenorphine with individuals leaving jail.
Gordon MS, Mitchell SG, Blue TR, Vocci FJ, Fishman MJ, Murphy SM, Couvillion K, Maher K, Ryan D, Wenzel K, Danner ML, Jarvis DK. Gordon MS, et al. Among authors: vocci fj. J Subst Abuse Treat. 2021 Sep;128:108241. doi: 10.1016/j.jsat.2020.108241. Epub 2020 Dec 11. J Subst Abuse Treat. 2021. PMID: 33339633 Free PMC article.
Health and economic outcomes of treatment with extended-release naltrexone among pre-release prisoners with opioid use disorder (HOPPER): protocol for an evaluation of two randomized effectiveness trials.
Murphy SM, Jeng PJ, Poole SA, Jalali A, Vocci FJ, Gordon MS, Woody GE, Polsky D. Murphy SM, et al. Among authors: vocci fj. Addict Sci Clin Pract. 2020 Apr 22;15(1):15. doi: 10.1186/s13722-020-00188-5. Addict Sci Clin Pract. 2020. PMID: 32321570 Free PMC article. Clinical Trial.
56 results